PurchasingPolicy.orgPURCHASINGPOLICYBETA
← Back to Influence Map
Entity DossierOrganization

Public Citizen

Organization identified through public comments on regulations.gov

Tracked direct giving

$0

Tracked donations to candidate

$0

Connections

9

Connection Graph
0 nodes · 0 edgesHover for labels · Double-click to expand
Loading graph...
Person
Organization
PAC
Gov Body
Legislature
Think Tank
Industry
Outcome

Click a node to see details

Double-click to expand its connections

Relationships

TypeConnected ToDetailsSource
Lobbied forPharmacy Benefit Manager Reform ActLDA filing: lobbied on PBM Reform Act, period 1st Quarter (Jan 1 - Mar 31), reported amount $90,000Source
Lobbied forInsulin Price Caps - State-Level LegislationLDA filing: lobbied on Insulin Price Caps, period 2nd Quarter (Apr 1 - June 30), reported amount $73,300Source
Lobbied forMARCH-IN Rights Proposal (NIH Framework)LDA filing: lobbied on NIH March-In Rights, period 2nd Quarter (Apr 1 - June 30), reported amount $72,000Source
Lobbied forOverdraft/NSF Fee Reforms (CFPB)LDA filing: lobbied on CFPB Overdraft Reform, period 1st Quarter (Jan 1 - Mar 31), reported amount $76,570Source
Lobbied forSugar Reform Act (S.832, 118th Congress)LDA filing: lobbied on Sugar Reform Act, period 1st Quarter (Jan 1 - Mar 31), reported amount $76,570Source
commented_onOffice of the Comptroller of the CurrencyPublic comment on OCC-2011-0001: Incentive-Based Compensation ArrangementsSource
Lobbied forRights to Federally Funded Inventions and Licensing of Government Owned InventionsLobbied on march-in — matched LDA filing topic to Federal Register rule.Source
commented_onFederal Trade CommissionPublic comment on FTC-2023-0064: Trade Regulation Rule on Unfair or Deceptive FeesSource
commented_onCenters for Medicare & Medicaid ServicesPublic comment on CMS-2025-1889: Global Benchmark for Efficient Drug Pricing ModelSource